XORTX Therapeutics (XRTX) Interest & Investment Income (2022 - 2026)
XORTX Therapeutics (XRTX) posted Interest & Investment Income of $1635.0 for Q1 2026, down 58.31% on a QoQ basis from $3922.0 in Q4 2025, and down 91.12% year-over-year from $18421.0 in Q1 2025.
XORTX Therapeutics (XRTX) Interest & Investment Income (2022 - 2026) Analysis & Trends
XORTX Therapeutics' Interest & Investment Income history runs 5 years deep, the most recent figure standing at $1635.0 for Q1 2026.
- Quarterly Interest & Investment Income fell 91.12% year-over-year to $1635.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25084.0 (down 76.93% YoY) and the FY2025 annual result came in at $41870.0, down 65.65% from the prior year.
- Interest & Investment Income was $1635.0 for Q1 2026 at XORTX Therapeutics, down from $3922.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $92782.9 in Q4 2023 and bottomed at -$54577.3 in Q2 2023.
- A 5-year average of $5748.4 and a median of $5561.5 in 2025 frame the typical range for Interest & Investment Income.
- Peak annual rise in Interest & Investment Income reached 334.46% in 2023, while the deepest fall reached 2262.78% in 2023.
- XORTX Therapeutics' Interest & Investment Income stood at -$39572.7 in 2022, then jumped by 334.46% to $92782.9 in 2023, then sank by 72.7% to $25331.0 in 2024, then plunged by 84.52% to $3922.0 in 2025, then plunged by 58.31% to $1635.0 in 2026.
- Business Quant data shows XRTX's Interest & Investment Income at $1635.0 in Q1 2026, $3922.0 in Q4 2025, and $7201.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | XORTX Therapeutics | 2.91 Bn | 2.91 Bn | - | 1,635.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,635.00 |
| Dec 31, 2025 | 3,922.00 |
| Sep 30, 2025 | 7,201.00 |
| Jun 30, 2025 | 12,326.00 |
| Mar 31, 2025 | 18,421.00 |
| Dec 31, 2024 | 25,331.00 |
| Sep 30, 2024 | 29,023.00 |
| Jun 30, 2024 | 35,952.00 |
| Dec 31, 2023 | 92,782.86 |
| Sep 30, 2023 | 47,451.62 |
| Jun 30, 2023 | -54,577.30 |
| Mar 31, 2023 | -49,413.20 |
| Dec 31, 2022 | -39,572.74 |
| Sep 30, 2022 | -27,188.82 |
| Jun 30, 2022 | -9,226.98 |
| Mar 31, 2022 | -2,091.32 |